4 Ways Ocrevus Can Improve Your Life


It can limit relapses. 
In addition to slowing the progression of the disease, Ocrevus has also been shown to stop relapses (in the trial, it halted the disease in nearly half of RMS patients) and improve symptoms. Many patients in the clinical trial saw reduced pain levels and improved brain function (a.k.a. less brain fog).

It can improve your body’s ability to move.
As MS progresses, walking often becomes more difficult. One of the key markers in the Ocrevus clinical trials was the walk test. Patients taking Orevus reduced the time required to walk 25 feet by 29 percent. In addition to walking ability, researchers studied MS patients ability to move their bodies on Ocrevus, and those scores improved as well.

MORE: Ocrevus approval: a quick cheat sheet

Multiple Sclerosis News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

How useful was this post?

Click on a star to rate it!

Average rating 5 / 5. Vote count: 1

No votes so far! Be the first to rate this post.

As you found this post useful...

Follow us on social media!

We are sorry that this post was not useful for you!

Let us improve this post!

Tell us how we can improve this post?


    • Tim Bossie says:

      At this moment it is not certain whether it will help with Secondary Progressive. There has been some indication that it can help, but the findings are not enough to make it available for it yet. Keep in contact with your doctor about it and stay tuned for out site for more info.

    • tim says:

      Uh, my uncle as secondary MS and is starting the treatment in two weeks. Please don’t listen to random people online, you have to call your doctor.

  1. Caro says:

    I participated in the study phase of the drug and turned out that I received the drug then called ocrelizumad and not the placebo.

    I get tested for walking, doing math calculations, taking pegs with hands and have been having the same type of results.

    I have PPMS and hope that this drug will compleately slow down the process of the disease. What I have lost will not be regained but I am still working 5 days a week, can manage stairs at home and use a walker for short distances at home.

    For me it is a positive result!

  2. Rebecca Ramirez says:

    Will it remylenate damaged myelin? If so, what percentage of patients demonstrate visible disability improvement and at what timeline?

  3. Bonnie says:

    How soon will the drug be available for use? My neurologist’s office said their pharmacy have not gotten the medication yet.

  4. Colleen says:

    Is PML a possible risk? … I have seen what PML can do (to another MS patient as a result of infusions of another med) and I won’t take that chance … haven’t seen it mentioned for this …

    • Erica says:

      It has not had PML reported but one patient had PML due to transitioning from Tysabri. People where trying to blame Ocrelizumab but it was not at fault doctor stated that patient already had symptoms of PML before ocrelizumab.
      PML is a risk for every DMDs but some are higher than others. At the moment ocrelizumab is lower than some of the others and that is why so many are switching over since they do need an aggressive treatment but one that meets risk in the middle.

Leave a Comment

Your email address will not be published. Required fields are marked *